GUETH ANTON
Insider CIK 1274940 · AIS Director · NAVB Director · SPPI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 80,318 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 58,246 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 46,729 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 76,548 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 48,542 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 150,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 99,395 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 61,930 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 1,800 | $5.60 | $10.1K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 79,645 | $5.60 | $446.0K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 386,132 | $5.60 | $2.16M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-07-08 | 2021-07-09 | 100,000 | $4.29 | $429.0K | 467,577 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 48,542 | — | $0 | 48,542 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 25,452 | $4.42 | $112.5K | 567,577 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-05-04 | 2021-05-06 | 40,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-05-04 | 2021-05-06 | 40,000 | $1.66 | $66.4K | 542,125 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-04-29 | 2021-05-03 | 72,669 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-04-29 | 2021-05-03 | 72,669 | $1.66 | $120.6K | 502,125 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 58,246 | — | $0 | 58,246 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 30,220 | $2.73 | $82.5K | 429,456 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2020-05-13 | 2020-05-15 | 72,487 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2020-05-13 | 2020-05-15 | 72,487 | $1.60 | $116.0K | 399,236 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 46,729 | — | $0 | 46,729 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 23,973 | $2.92 | $70.0K | 326,749 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 76,548 | — | $0 | 76,548 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 80,318 | — | $0 | 80,318 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-03-18 | 2016-03-21 | 50,000 | $0.72 | $36.0K | 302,776 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2016-01-06 | 2016-01-08 | 16,918 | $1.22 | $20.6K | 38,918 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2015-07-02 | 2015-07-06 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 99,395 | — | $0 | 99,395 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2014-08-11 | 2014-08-13 | 5,000 | $2.00 | $10.0K | 252,776 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 61,930 | — | $0 | 268,881 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-09-03 | 2013-09-05 | 25,000 | $4.42 | $110.5K | 245,976 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-08-01 | 2013-08-05 | 25,000 | $4.41 | $110.3K | 270,976 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-07-01 | 2013-07-03 | 25,000 | $4.15 | $103.8K | 295,976 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-06-03 | 2013-06-05 | 25,000 | $4.01 | $100.3K | 320,976 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 27,778 | — | $0 | 345,976 | SEC↗ |
| SPPI SPECTRUM PHARMACEUTICALS I | A Award deriv | 2012-12-19 | 2012-12-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPPI SPECTRUM PHARMACEUTICALS I | A Award | 2012-12-19 | 2012-12-21 | 10,000 | $11.34 | $113.4K | 11,000 | SEC↗ |
| AIS ANTARES PHARMA, INC. | S Sale | 2012-05-30 | 2012-05-31 | 87,500 | $2.85 | $249.4K | 318,198 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 500 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 5,750 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 500 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 16,500 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 2,000 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 2,000 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 2,000 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 500 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 2,000 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 1,250 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 20,000 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 10,000 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 1,250 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 40,000 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 26,009 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 20,000 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 174,849 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 105,616 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise deriv | 2012-05-29 | 2012-05-31 | 61,870 | — | $0 | 0 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 16,500 | $1.06 | $17.5K | 101,891 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 195 | $2.90 | $566 | 85,391 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 500 | $1.13 | $565 | 85,586 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 2,578 | $2.90 | $7.5K | 85,086 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 5,750 | $1.30 | $7.5K | 87,664 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 6,031 | $2.90 | $17.5K | 95,860 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 2,000 | $1.10 | $2.2K | 97,860 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 759 | $2.90 | $2.2K | 97,101 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 2,000 | $1.40 | $2.8K | 99,101 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 966 | $2.90 | $2.8K | 98,135 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 500 | $1.32 | $660 | 98,635 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 228 | $2.90 | $661 | 98,407 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 2,000 | $1.01 | $2.0K | 100,407 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 697 | $2.90 | $2.0K | 99,710 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 500 | $0.95 | $475 | 100,210 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 164 | $2.90 | $476 | 100,046 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 2,000 | $0.90 | $1.8K | 102,046 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 621 | $2.90 | $1.8K | 101,425 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 302 | $2.90 | $876 | 102,373 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 1,250 | $0.70 | $875 | 102,675 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 35,202 | $2.90 | $102.1K | 154,067 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 61,870 | $1.65 | $102.1K | 189,269 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 5,345 | $2.90 | $15.5K | 127,399 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 10,000 | $1.55 | $15.5K | 132,744 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 10,621 | $2.90 | $30.8K | 122,744 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 20,000 | $1.54 | $30.8K | 133,365 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 9,655 | $2.90 | $28.0K | 113,365 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 20,000 | $1.40 | $28.0K | 123,020 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 603 | $2.90 | $1.7K | 103,020 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 1,250 | $1.40 | $1.8K | 103,623 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 30,956 | $2.90 | $89.8K | 228,727 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 174,849 | $0.53 | $92.7K | 403,576 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 105,616 | $0.85 | $89.8K | 259,683 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 26,009 | $1.10 | $28.6K | 397,630 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 9,865 | $2.90 | $28.6K | 387,765 | SEC↗ |
| AIS ANTARES PHARMA, INC. | M Exercise | 2012-05-29 | 2012-05-31 | 40,000 | $1.60 | $64.0K | 427,765 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 22,067 | $2.90 | $64.0K | 405,698 | SEC↗ |
| AIS ANTARES PHARMA, INC. | F Tax w/h | 2012-05-29 | 2012-05-31 | 31,955 | $2.90 | $92.7K | 371,621 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award | 2012-05-17 | 2012-05-21 | 30,914 | — | $0 | 81,914 | SEC↗ |
| SPPI SPECTRUM PHARMACEUTICALS I | A Award deriv | 2012-03-30 | 2012-04-02 | 7,500 | — | $0 | 7,500 | SEC↗ |